“ Novartis Italy's Georg Schroeckenfuchs discusses the impact of the company's global restructuring on the Italian affiliate, the significance of local manufacturing, new products, and how the… ”
In Conversation
“ Giuseppe Martini, President at the National Technological Cluster: Advanced Life Sciences in Italy (ALISEI) discusses the founding of the ALISEI cluster, its main missions and how… ”
“ Jean-Luc Bélingard, chairman of bioMérieux, reveals how the medical community in France has a unique profile, combining both clinical and technological experience, leading to what he… ”
“ Elena Tremoli, Scientific Director at ”
“ Eugenio Aringhieri discusses Dompé's shift in strategy towards opthalmology, instilling an innovation mindset, and broadening the company's international horizons. ”
“ Stéphane Bouchard reveals why BD's pharmaceutical systems centre of excellence is based in France; BD's increased strength in medical devices following the acquisition of CareFusion in 2015; and why cooperation and… ”
“ Pier Mannuccio Mannucci, Scientific Director of the ”
“ The President and MD of Abiogen Pharma discusses his family company's recent milestones, the reasons for persisting with local manufacturing, and the benefits of international partnerships. ”
“ Frédéric Duchesne, President & CEO of Pierre Fabre's pharmaceuticals division, talks about the ”
“ While functional outsourcing may be common for companies seeking services from CROs, Medpace believes that their robust, physician-led, full-service business model is the most efficient way… ”
“ "A commitment to therapeutic progress for the benefit of the patient is our key concern." ”
“ Stéphane Thiroloix, CEO of the independent and family owned Mayoly Spindler, reveals how their vision is to become a reference company internationally in the field of… ”
